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The vocal fold structure is composed of tissues with many 
cells surrounded by the extra-cellular matrix. One of the 
most important components of the extra-cellular matrix is 
Hyaluronic Acid (HA). The aim of the study was to evaluate 
the inflammatory response of rabbit vocal folds after a local 
injection of Restylane® HA. Methods-Twelve adult male 
rabbits randomly received a 0.1 ml injection of Restylane® 
HA in one vocal fold and 0.1 ml of saline in the other vocal 
fold. The animals were prospectively subdivided into two 
groups; animals in one group were sacrificed after one week 
of follow-up and animals in the other group were sacrificed 
after 3 months. Slides were Hematoxylin-Eosin (HE), Masson 
Trichromic and Toluidine Blue stained. Results- Hyaluronic 
Acid was found microscopically in all specimens in both 
groups. There was more connective tissue surrounding 
HA, always associated with a mild inflammatory response. 
The longer exposure time did not increase the intensity of 
inflammation. Tissue necrosis and foreign body inflammatory 
reaction were not observed in both groups. Conclusion-
The study suggests that HA is a good alternative as a filling 
material in vocal folds when treating glottal insufficiency.
Keywords: inflammatory, vocal fold insufficiency, ocal cord, 
hoarseness, hyaluronic acid.
ORIGINAL ARTICLE
Rev Bras Otorrinolaringol
2007;73(2):171-8.
172
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 73 (2) MARCH/APRIL 2007
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
INTRODUCTION
Scientists studying the human voice have always 
sought a feasible alternative to correct glottal insufficiency. 
This entity is characterized by incomplete glottal closure - 
seen under stroboscopy - while emitting a sustained vowel 
at a comfortable intensity and pitch. Normal phonation 
depends, among other factors, on complete glottal closure 
and malleability of the vocal fold (VF) mucosa, which are 
the main determinants of good voice quality.
Professor Isshiki conducted experiments on excised 
larynxes and elegantly demonstrated the need for perfect 
glottal closure; in other words, an investigation of the 
initial glottic area with no subglottic air flow (Ag0). If this 
condition is not met, glottal closure will be imperfect, re-
sulting in slits that cause the turbulent flow of infraglottic 
air instead of a physiological laminar air flow.1 
The structure of laryngeal tissues, which is com-
posed of layers with different viscoelastic properties, is 
essential for adequate voice production. Soft tissues that 
form the vocal folds (VFs) are far more complex than 
originally thought. They are formed by thin lubricated 
layers in intimate contact with the ipsilateral tissues, allo-
wing the onset of VF wavelike movement at the moment 
of complete glottal closure. This phenomenon was well 
studied in past decades by Professor Hirano, who revolu-
tionized our understanding of voice physiology with the 
body/cover theory.2
Various authors in recent papers have underlined 
the importance of the VF ultra-structure, emphasizing the 
extracellular matrix (EM), and have defined its protein 
components. These substances, which include hyaluronic 
acid (HA), are responsible for the viscoelastic properties 
of VFs.3-5 
The EM is composed of fibrous proteins and inters-
titial elements. Fibrous proteins, which include elastin and 
collagen, provide support to the EM and give VFs the abi-
lity to withstand external pressure. Interstitial components 
include proteoglycans and glycoproteins, which envelop 
the fibrous elements. These components have biological 
features that influence cell function, such as osmosis, cell 
migration, cell differentiation, molecule transport, and 
molecule concentration. Based on these characteristics, 
we believe that manipulation of EM elements might result 
in the discovery of valuable treatments in a wide variety 
of VF conditions.
Minor quantitative changes in these macromolecules 
can result in a marked negative impact on the biomecha-
nical properties of the VF extracellular matrix, such as 
oscillation and propagation of the mucous wave (muco-
ondulatory component).
An ideal substance to substitute live tissues has 
been reason for much medical research. For VF surgery 
this prospective ideal substance should have the following 
characteristics: 
1 - be made of a single substance; 
2 - be non-immunogenic; 
3 - be non-toxic; 
4 - not produce inflammation; 
5 - able to be used as an injection with no major 
trauma; 
6 - to remain in the host for a long period; 
7 - to be biocompatible at the application site. As 
VFs are the host site in our case, this proposed substance 
should not interfere with VF oscillation.6-8
Various substances have been used in attempts 
to recompose glottal closure and the VF mucous wave. 
Brünings (1911) apud,9 described the first substance to be 
implanted in VFs, namely liquid paraffin for the treatment 
of patients with recurrent nerve palsy. Although the author 
described few complications, widespread use of paraffin 
resulted in significant side effects such as granulomas 
and migration of the injected material to lymphnodes of 
the neck.
Other synthetic substances have been used with 
similar aims, such as tetrafluoroethylene (Teflon) and 
silicone, all with undesirable side effects such as granulo-
mas - which are hard to remove - and migration to other 
sites.10,11
These negative results have fostered the search for 
biologically compatible materials to be used as VF space 
fillers, among which are collagen and fat. Unfortunately, 
these materials have also shown undesirable effects such as 
resorption. Immunogenic effects have also been observed 
against bovine collagen. Fat required multiple applications 
due to intense resorption.12,13
Unpredictability in the resorption rate of these biolo-
gical materials has encouraged a search for biocompatible 
materials with lower or absent resorption in host tissues. 
These studies included biological materials that have lower 
resorption rates after undergoing structural change; HA is 
one of these materials.
Various factors should be observed when choosing 
a biomaterial to be implanted in VFs. These include: ease 
of implantation, the type of immune response, migration 
of the material to undesired regions, the possibility of in-
jecting a larger amount of material without causing harm 
to the host, and duration of the implant.6
Chan & Titze (1999) compared various VF implanta-
ble materials and showed that the viscoelastic properties of 
HA were similar to those of the normal VF lamina propria 
in men and women.
VF viscoelastic properties require a higher or lower 
phonation pressure to generate Bernoulli’s phenomenon. 
It is assumed that lack of HA causes voice changes, as 
HA is the main component of the VF extracellular matrix 
responsible for its viscoelasticity. In this case replacing HA 
as a biological implant might be a solution for this group 
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of conditions.
HA in its natural state has been used since the 1980s 
to improve healing of tympanic membrane perforations. 
Sten & Laurent (1987) used HA experimentally in rats with 
traumatic tympanic membrane perforation. This group 
was compared to another group of untreated rats, and 
the result was faster closure in the HA-treated group. This 
group also has less residual scarring.
Artificial forms of HA are widely used in other parts 
of the body, such as in joints, in the eye and intradermally 
to fill in facial lines and wrinkles. Various papers have 
shown that HA is not completely inert in biological tissues. 
There have been complications such as erythema immedia-
tely after HA application. Late reactions - between six and 
eight weeks - have also been noted, including significant 
inflammation, including subcutaneous abscesses. Lowe et 
al. (2001) declared, based on observation, that these agents 
clearly have the potential to cause skin reactions.
Duranti et al. (1998) found a 12.5% rate of local 
and transitory immediate adverse effects after intradermal 
injection of HA, the most significant being local swelling in 
the application site. When HA was used to alleviate joint 
pain, adverse effects were related to the original disease, 
not to the treatment.18
There have been few studies on HA used in VFs. 
Most papers about HA describe its use in plastic surgery, 
orthopedics and ophthalmology rather than otorhinola-
ryngology, which undoubtedly underlines the need for 
animals studies prior to application of this material in 
humans.
A first study on the use of HA in VFs was done 
in 1998 by Hallen et al., who investigated a mixture of a 
hyaluronic acid solution in its natural state with dextra-
nomere microspheres (DiHA) injected in rabbit VFs. This 
material contains equal parts of microspheres (80 to 120µm 
dextranomeres) and a 1% HA solution. The dextranome-
re particles are dry and porous, consisting of a strongly 
hydrophilic three-dimensional structure linked to a dextran 
molecule. This study showed that application of DiHA 
produced collagen fiber neoformation enveloping dextra-
nomere microspheres and a weak inflammatory reaction, 
but no foreign body reaction. The authors concluded that 
HA is a perfect vehicle for DiHA due to its viscoelasticity, 
allowing injection with no significant trauma.
The combination of HA with dextranomere micros-
pheres resulted in longer stay of the material implanted in 
VF soft tissues, collagen formation, increased dextranomere 
microsphere permanence in tissues up to six months - the 
follow-up period after VF injection - and complete absorp-
tion of HA; finally, there was only a weak inflammatory 
reaction throughout the 6-month period.
Endogenous HA solutions do not have the necessary 
rheological properties (viscosity, elasticity, and stability) to 
be used in VF space-filling surgery; these solutions are not 
sufficiently viscoelastic and remain in soft tissues for short 
periods, which make them unsuitable for such procedu-
res. A chemical process based on the reaction of divinyl 
sulphone (DVS) linked to the HA hydroxyl radical in an 
aqueous alkaline solution at room temperature to form a 
HA gel was used to improve the physical and chemical 
characteristics and the stability of HA. This process is 
named cross-linking of HA, which has given rise to trade 
names (Restylane® Hyalgan® and Hylaform®).8
Hallen et al. (1999) used rabbits to study the histo-
logical behavior of HA that had been extracted from the 
cockscomb and cross-linked (Hylan b gel), different from 
microsphere-containing DiHA. HA in its Hylan b gel form 
was injected in rabbit VFs. No foreign body reaction was 
seen, and the authors concluded that chemical modifica-
tion of HA into the Hylan b gel form increased stay of this 
substance in VF tissues without causing significant inflam-
mation or other adverse reactions. Based on these results, 
the authors concluded that this material might be useful to 
correct glottal insufficiency of any cause in humans.
Hertegard et al. (2002) compared HA Hylan b gel 
(cross-linked) and bovine collagen in a series of patients, 
concluding that Hylan b gel and bovine collagen may be 
safely used as injections for treating glottal insufficiency. 
Both methods showed improvement of voice quality para-
meters. Hylan b gel-treated patients showed the best results 
in maximum phonation time 12 months after treatment, 
compared with collagen-treated patients.
Scarring of the lamina propria causes serious pho-
nation disorders by altering the VF viscoelastic properties 
and modifying phonation physiology. Constant research, 
therefore, has been conducted to find a substance that 
might fill in Reinke’s space without altering its rheological 
properties.
We decided to study the histological behavior of 
another presentation of HA - extracted from a Streptococus 
culture (Restylane®) - based on the important influence 
HA has over the quality of viscoelastic properties of the 
VF lamina propria surface layer and the encouraging 
results from implanting Hylan b gel (extracted from the 
cockscomb) in rabbit and human VFs.
Careful control must be obtained when applying 
saline in the ipsilateral VF in rabbits, as this traumatic 
procedure in itself might cause local inflammation and 
give rise to fibroblast-mediated regeneration. This type of 
control was not made in previous studies with Hylan b 
gel (cockscomb). This paper aimed to assess the safety of 
using HA Restylane after injection in rabbit VF, to study 
its histological behavior, and to compare this behavior 
with the ipsilateral fold that received an injection of saline 
(control group). The Research Ethics Committee approved 
the design and execution of this study in protocol number 
41, dated 01 July 2003.
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MATERIAL AND METHODS
 
The product: Restylane®
Restylane® is currently sold in Europe and was 
approved under the rules of the Council Directive 43/42 
/EEC ANNEX II. It is produced from an equine Strepto-
coccus culture by fermentation with sugar; the fermented 
material is precipitated in alcohol, filtered and dried. HA 
chains are chemically stabilized by a cross-linking process 
and its molecules are altered by only 1%. The result is a 
2% viscoelastic, transparent, injectable, non-water solu-
ble gel at a 20g/ml concentration, with high affinity for 
preserved water, and the ability to gain volume and form 
hydrated polymers.
 
Selection of animals
We selected twelve healthy New Zealand male adult 
rabbits weighing between 2.8 kg and 3.9 kg, obtained 
from the biotherium of the Sao Paulo Santa Casa Medical 
Science School (FCMSCSP).
The protocol followed the guidelines for experimen-
tal surgery of the FCMSCSP Research Ethics Committee.
 
Surgical technique
Surgery was done under intramuscular anesthesia 
with Vetarnacolâ (ketamine chloridrate - 20 to 25mg/kg), 
Anasedanâ (xylazine chloridrate - 1.5 ml for each 10kg 
weight). No preanesthetic medication was used.
The animals were placed in decubitus on the sur-
gical table with the front limbs parallel to the body. The 
larynx was presented by restraining the tongue with gauze 
to expose the hypopharynx; the larynx was then visualized 
using a Storz® zero degree nasal endoscope and a 200-
Watt Storz® light source.
Under spontaneous breathing, we first injected 
0.1ml of saline in one of the VFs chosen randomly, which 
was considered the control VF, followed by injection of 
0.1ml of HA (Restylane®) in the ipsilateral VF. The fine 
needle we used was the 27 gauge 35 cm needle that is 
employed in spinal anesthesia.
Restylane® may be kept at room temperature; 
when opened, it must be used within hours. It may not 
be resterilized or used with other substances. It is easy to 
inject and there is no need for manual pressure or special 
syringes.
 
Study groups
The study sample included 12 rabbits that were divi-
ded into 2 groups of 6 rabbits selected randomly. Definition 
of the groups was done after surgery by a draw based on 
an increasing number scale. The first group was sacrificed 
one week after the procedure (group I) and the second 
group was sacrificed after three months (group II).
The choice of which VF would receive the HA 
injection was defined at the beginning of surgery. The 
control was the VF receiving a saline injection.
 
Histological study
Histology was done at the FCMSCSP pathology 
department. HA-injected or saline-injected (control) he-
milarynxes were assessed by an examiner who did not 
know to which groups each belonged. Fixation was done 
with formaldehyde at 10% for 24 hours. Coronal three-
micrometer thick sections through the VF membranous 
portion were made. Sections were hematoxilin-eosin (HE), 
Masson’s trichrome, and toluidine blue stained.
Histology was done using a Zeiss® conventional 
optic microscope to assess inflammatory cell intensity and 
predominance, neovascularization, fibrogenesis and areas 
of necrosis.
The inflammatory infiltrate was assessed according 
to intensity using a weighting or ponderal index divided 
into four grades: Grade 0, absent; Grade 1, mild; Grade 
2, moderate; and Grade 3, intense (Chart 1). Predominant 
cell types are also described: neutrophils (N), mast cells 
(M), lymphocytes (L), plasmocytes (P), histiocytes (H), 
eosinophils (E), lymphohistiocytic (LH), and lymphoplas-
macytic (LP).
Fibrogenesis was quantified using an intensity scale 
as follows: Grade 0, absent; Grade 1, mild; Grade 2, mode-
rate; and Grade 3, intense (Chart 1). The fibrous pseudo-
capsule around the injected material was not considered in 
measurements of intensity of fibrosis. Neovascularization 
and areas of necrosis were described as absent (Grade 0) 
or present (Grade 1) (Chart 2).
Chart 1. Intensity of the inflammatory infiltrate according to the pre-
sence of cells and intensity of fibrosis.
Grade 0 Absent
Grade 1 Mild
Grade 2 Moderate
Grade 3 Intense
Chart 2. Neovascularization and Necrosis.
Grade 0 Absen
Grade 1 Present
Analysis of results
The intensity of VF inflammation after HA injec-
tion was compared to that in the ipsilateral VF for the 
two time periods: one week and three months after the 
procedure.
A comparative study of cell types (neutrophils, mast 
cells, lymphocytes, plasmocytes, histiocytes and eosino-
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phils) found in HA-injected VFs compared to ipsilateral 
saline-injected VFs was done for the two time periods.
Fibrosis in HA-injected VFs was compared to that in 
ipsilateral saline-injected VFs for the two time periods.
The progression of analysis parameters (inflamma-
tion intensity and cellularity, neovascularization, necrosis, 
and fibrosis) was studied for both groups in the two time 
periods to detect changes in time. These may be seen in 
the following tables that show the groups and analysis 
parameters.
Two rabbits died before the seventh day. Rabbit 
number 01 presented acute respiratory failure immediately 
after surgery and died 24 hours later. Rabbit number 12 
died on the third day of unknown causes.
DISCUSSION
HA Restylane® was chosen due to ease in handling, 
ready availability in the Brazilian market, storage at room 
temperature, and for being the first FDA-approved HA 
(December 2003). It is an affordable product that is avai-
lable as a cross-linked gel and is a natural material with 
significant biocompatibility and low immune reactivity; it 
is also non-carcinogenic. The product does not cause sig-
nificant infection, and is an excellent choice in surgery for 
correcting free edge of VF scars or as a space filler.19-22
Macroscopically it was difficult to define which 
of the VF had been HA-injected. Thus, in four paraffin-
included specimens, deeper sections had to be made to 
find HA.
Curiously in rabbit 10 we found that HA was located 
in two different sites, the submucosa and muscle. Proba-
bly during application, the needle moved at the moment 
HA was being injected. It is almost impossible to obtain 
complete VF immobility only with sedation; under spon-
taneous breathing it is difficult to inject HA in VFs with 
precision and reproducibility, as VFs move very rapidly 
in certain sites.23 In our study the substance was found in 
different levels of the VFs.
Rabbit 5 presented acute respiratory failure and 
received maximum concentration O
2
 ventilatory support, 
eventually progressing with no further problems. These 
animals are very sensitive to handling of the glottis, easily 
developing glottal edema which may progress to acute 
respiratory failure and eventual death of the animal.
Rabbits number 01 and 12 died of acute infection, 
which was seen on histopathology. Sepsis was clearly 
Group I: One week
Table 1. Group I - vocal fold control.
Order Infiltrate
Cell predo-
minance
Neovascu-
larization
Fibro-
genesis
Necro-
sis
7 1 N 0 0 0
8 0 - 0 0 0
9 0 - 0 0 0
10 0 - 0 0 0
11 0 - 0 1 0
Tablel 2. Group I - vocal fold with hyaluronic acid.
Order Infiltrate
Cell predo-
minance
Neovascu-
larization
Fibroge-
nesis
Necrosis
7 2 LH 1 3 0
8 1 LP 1 1 0
9 1 L 1 1 0
10 2 LH 0 0 0
11 1 LH 1 1 0
Identification of the animal (Order). Intensity of 
inflammation (Infiltrate): mild (1), moderate (2), intense 
(3). Predominant cells: lymphoplasmacytic (LP), lym-
phohistiocytic (LH), lymphocytic (L), neutrophilic (N). 
Neovascularization. Absent (0), Present (1). Fibrogenesis: 
absent (0), mild (1), moderate (2), intense (3). Necrosis: 
absent (0), present (1).
Group II - 3 months
Table 3. Group II - vocal fold control.
Order Infiltrate
Cell predo-
minance
Neovascu-
larization
Fibroge-
nesis
Necro-
sis
2 0 - 0 0 0
3 0 - 0 0 0
4 0 - 0 0 0
5 0 - 0 0 0
6 0 - 0 0 0
Table 4. Group II - vocal fold with hyaluronic acid
Order Infiltrate
Cell predo-
minance
Neovascu-
larization
Fibroge-
nesis
Necro-
sis
2 1 L 0 1 0
3 0 - 0 1 0
4 1 LH 0 1 0
5 1 LH 1 1 0
6 0 - 0 1 0
Identification of the animal (Order). Intensity of 
inflammation (Infiltrate): mild (1), moderate (2), intense 
(3). Predominant cells: lymphoplasmacytic (LP), lym-
phohistiocytic (LH), lymphocytic (L), neutrophilic (N). 
Neovascularization. Absent (0), Present (1). Fibrogenesis: 
absent (0), mild (1), moderate (2), intense (3). Necrosis: 
absent (0), present (1).
Identification of the animal (Order). Intensity of 
inflammation (Infiltrate): mild (1), moderate (2), intense 
(3).
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demonstrated by the presence of many piocytes and 
significant amounts of necrotic material. During the final 
moments of this process, these rabbits were tachypneic 
and probably developed severe glottal edema that caused 
their deaths. Although the procedure is a simple injection 
in VFs, careful antisepsis of materials used in the procedure 
is required, as in any other experimental study.23,24
The aim of injecting a substance in VFs in cases 
of VF palsy is to increase the volume of palsied VFs and 
scars and to fill in Reinke’s space, preserving its viscoelastic 
and rheological properties. HA Restylane® is a promising 
substance in this context; it did not migrate or degrade, and 
is water insoluble. In this study we found that there was 
perfect integration between HA and host tissues (Figures 
1 and 2), with collagen regeneration of connective tissue, 
mild fibrosis, and VF augmentation due to formation of 
new connective tissue (Figure 3).
A few empty spaces were observed within HA blo-
cks in some sections in both groups. This probably is due 
to ’suction’ of tissues enveloping the gel during the histolo-
gical fixation process, since the gel is water-insoluble; this 
finding has been previously reported in literature.23
Different from collagen, HA Restylane® was well 
tolerated and remained stable throughout the study period 
in all tissues (Figure 3), presenting the same histological 
pattern regardless of the host tissue.14 It may become a 
useful indication for cases in which the superficial lamina 
propria layer requires recovery so as to correct free edge 
of VF irregularities (Figure 4).
This study demonstrated that HA Restylane® injec-
ted in rabbit VFs remains for up to three months, forming 
new connective tissue. Hallen (1999) states that new con-
nective tissue increased with time of stay. This finding is 
in conflict with our results, where in the one week group 
90% of rabbits had moderate fibrosis (falling to 10% on 
the third month); the percentage difference progressed to 
mild or absent fibrosis. These results show that fibrosis 
Figure 1. Rabbit 7 - left vocal fold, highlighting hyaluronic acid framen-
ted by fibrosis and vascular neoformation. (x 100, HE).
Figure 2. Rabbit 10 - right vocal fold, presence of blocks of hyaluronic 
acid within the muscle, enveloped by a thin pseudocapsule (x 100, 
HE).
Figure 3. Rabbit 3 - right vocal fold, note hyaluronic acid in the lamina 
propria, with mild fibrosis. The highlight shows the presence of carti-
lage. (x 100, HE).
Figure 4. Rabbit 5 - left vocal fold, predominance of a thin pseudo-
capsule enveloping hyaluronic acid within the thyroarytenoid muscle. 
There is a mild macrophage infiltrate. (x 100, HE).
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diminished with time, which is important to allow sliding 
of the lamina propria over the vocal muscle.
The receptor area affects the behavior of injected 
material. Rabbit VFs have a squamous stratified epithelium 
(four layers); below the epithelium there is a dense layer of 
collagen fibers, which some authors describe as the vocal 
ligament.25 There is loose connective tissue between the 
epithelium and the thyroarytenoid muscle, and its funda-
mental substance is rich in HA,26 similar to the superficial 
layer of the lamina propria in humans.29 Significant local 
mobility is undoubtedly a factor that may interfere with 
the success of HA application. This mobility may cause 
material to be expelled, with loss of the injected substance.7 
Choice of the material should take into account physical 
property similarities with the application site. The material 
should also be able to mould itself, ameliorating the effects 
of mobility. It should meet local needs, namely resistance 
to stretching and to compression, and - in the specific case 
of VFs - the substance should attenuate impact during 
phonatory vibration (cushion effect). HA meets these VF-
related physical property requirements.16
Mild inflammation, complete absence of foreign 
body reactions, absence of necrosis and granuloma for-
mation, and negligible fibrogenesis observed with HA 
Restylane® during the study period, suggests that this is 
a potentially biocompatible and non-bioactive material. 
Complete integration of HA with VF tissues was not seen; 
thus, injected HA does not recompose the muco-ondu-
latory component, and has only a space filling function. 
Biocompatibility, ease of storage, an injectable form, and 
affordability suggests that HA Restylane® is a safe and 
valuable choice for the repair of anatomical alterations in 
VF stratification. In future this product may possibly be 
widely used in the larynx.
CONCLUSION
1. Injection of HA Restylane® in rabbit VFs does 
not cause significant inflammation.
2. HA Restylane® remained in the rabbit VF for 
three months.
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